OBJECTIVE: To evaluate the ability of third- and fourth-year pharmacy students to identify clinically significant drug-drug interactions (DDIs) METHODS: A questionnaire designed to measure DDI knowledge was disseminated to fourth-year pharmacy students in a school of pharmacy. A second questionnaire was distributed to third-year pharmacy students in 2 schools of pharmacy (schools A and B) and re-administered to students in 1 of the schools 1 year later. RESULTS: Class of 2005 fourth-year pharmacy students correctly categorized an average of 52% +/- 13% DDI pairs on the first questionnaire. Third-year pharmacy students at schools A and B correctly categorized an average of 61% +/- 18% and 66% +/- 15% of DDI pairs, respectively. The average percentage of correct responses for fourth-year students from the class of 2007 was 65% (+/- 17%). CONCLUSION: Pharmacy students' ability to identify important DDIs is far from optimal, even after completing experiential requirements.
OBJECTIVE: To evaluate the ability of third- and fourth-year pharmacy students to identify clinically significant drug-drug interactions (DDIs) METHODS: A questionnaire designed to measure DDI knowledge was disseminated to fourth-year pharmacy students in a school of pharmacy. A second questionnaire was distributed to third-year pharmacy students in 2 schools of pharmacy (schools A and B) and re-administered to students in 1 of the schools 1 year later. RESULTS: Class of 2005 fourth-year pharmacy students correctly categorized an average of 52% +/- 13% DDI pairs on the first questionnaire. Third-year pharmacy students at schools A and B correctly categorized an average of 61% +/- 18% and 66% +/- 15% of DDI pairs, respectively. The average percentage of correct responses for fourth-year students from the class of 2007 was 65% (+/- 17%). CONCLUSION: Pharmacy students' ability to identify important DDIs is far from optimal, even after completing experiential requirements.
Authors: Catherine C Peng; Peter A Glassman; Iny R Marks; Curtis Fowler; Brenda Castiglione; Chester B Good Journal: J Manag Care Pharm Date: 2003 Nov-Dec
Authors: Jacob Abarca; Daniel C Malone; Edward P Armstrong; Amy J Grizzle; Philip D Hansten; Robin C Van Bergen; Richard B Lipton Journal: J Am Pharm Assoc (2003) Date: 2004 Mar-Apr
Authors: David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier Journal: JAMA Date: 2003-04-02 Impact factor: 56.272
Authors: Wayne A Ray; Katherine T Murray; Sarah Meredith; Sukumar Suguna Narasimhulu; Kathi Hall; C Michael Stein Journal: N Engl J Med Date: 2004-09-09 Impact factor: 91.245
Authors: Yu Ko; Daniel C Malone; Grant H Skrepnek; Edward P Armstrong; John E Murphy; Jacob Abarca; Rick A Rehfeld; Sally J Reel; Raymond L Woosley Journal: Drug Saf Date: 2008 Impact factor: 5.606
Authors: Amanda R Harrington; Terri L Warholak; Lisa E Hines; Ann M Taylor; Duane Sherrill; Daniel C Malone Journal: Am J Pharm Educ Date: 2011-12-15 Impact factor: 2.047
Authors: Adrienne M Gilligan; Terri L Warholak; John E Murphy; Lisa E Hines; Daniel C Malone Journal: Am J Pharm Educ Date: 2011-08-10 Impact factor: 2.047